26 Facts About Barbara Sahakian

Barbara Sahakian is an honorary clinical psychologist at Addenbrooke's Hospital, Cambridge.

Barbara Sahakian has an international reputation in the fields of cognitive psychopharmacology, neuroethics, neuropsychology, neuropsychiatry and neuroimaging.

Barbara Sahakian is currently president of the International Neuroethics Society, of which she is a founder member.

Barbara Sahakian is past president of the British Association for Psychopharmacology, having served as president from 2012 to 2014.

Barbara Sahakian is best known for her work on cognitive enhancement using pharmacological treatments, early detection of Alzheimer's disease, cognition and depression and neuroethics.

Barbara Sahakian's research is aimed at understanding the neural basis of cognitive, emotional and behavioural dysfunction to develop more effective pharmacological and psychological treatments.

In 2007, Barbara Sahakian raised concerns regarding the ethics of using drugs intended to help dementia and Alzheimer's patients to instead enhance cognitive function in healthy people.

In May 2014, Barbara Sahakian published an article on the subject of achieving brain health for a flourishing society within the next decade.

Barbara Sahakian was asked to write this article for Sir John Beddington, Chief Scientific Adviser to the UK Government.

Barbara Sahakian has published over 400 papers covering these topics in scientific journals, including many publications in the prestigious scientific and medical journals Science, Nature, Nature Neuroscience, The Lancet, and the British Medical Journal.

Barbara Sahakian is a London Imperial Affiliated Professor and a Distinguished Research fellow at the Oxford Uehiro Centre for Practical Ethics.

Previously, Barbara Sahakian has been a member of the MRC Neurosciences and Mental Health Board and a member of the Society for Neuroscience Committee on Women in Neuroscience.

Barbara Sahakian's research uses neuropsychological tests, such as the Cambridge Neuropsychological Test Automated Battery tests, which she co-invented in the 1980s.

Barbara Sahakian serves as a Senior Consultant to Cambridge Cognition, a spin-out of the University of Cambridge.

Barbara Sahakian is a lead on many high-impact international neuroscience and mental health policy reports, including the National Institute of Mental Health funded report on Grand Challenges in Global Mental Health and the UK Government Foresight Project on Mental Capital and Wellbeing in 2008.

Barbara Sahakian recently presented on neuroscience and mental health policy at the World Economic Forum 2014 in Davos, Switzerland.

Barbara Sahakian is a Member of the WEF Global Agenda Council on Brain Research.

Barbara Sahakian frequently engages the public in science, appearing on programmes such as BBC Newsnight, and on both The Life Scientific and the Today Programme on BBC Radio 4.

Barbara Sahakian has taken part in numerous newspaper interviews, such as The Sunday Times and Forbes Online.

In 2012, Barbara Sahakian contributed to the catalogue and appeared in a video for the Wellcome Trust Superhuman Exhibition.

Since 2004, Barbara Sahakian has been a Fellow of the Academy of Medical Sciences.

Barbara Sahakian is a Member of the International Expert Jury for the 2017 Else Kroner-Fresenius-Stiftung Prize.

Barbara Sahakian was he was appointed to the F C Donders Chair of Psychopharmacology at the University of Utrecht in 2005 and the Distinguished International Scholar Award at the University of Pennsylvania in 2009.

In 2008, Barbara Sahakian gave the Alfred Deakin Innovation Lecture in Melbourne, Australia.

In 2015, Barbara Sahakian was awarded a Doctor of Science degree from the University of Cambridge, which is the highest degree awarded by the university for distinguished research in science.

In July 2017, Barbara Sahakian was elected a Fellow of the British Academy, the United Kingdom's national academy for the humanities and social sciences.